Senseonics Holdings (SENS) Stock Price, Quote & News

Latest News on SENS

Jun 4, 2025, 4:05 PM EDT - 4 days ago

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

May 21, 2025, 5:06 PM EDT - 18 days ago

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement

May 21, 2025, 3:35 AM EDT - 19 days ago

Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity

May 15, 2025, 11:12 PM EDT - 24 days ago

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 15, 2025, 4:05 PM EDT - 24 days ago

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 8, 2025, 7:55 PM EDT - 4 weeks ago

Senseonics Holdings, Inc. (SENS) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 4:05 PM EDT - 5 weeks ago

Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

Apr 29, 2025, 7:30 AM EDT - 5 weeks ago

Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)

Mar 3, 2025, 6:29 PM EST - 3 months ago

Senseonics Holdings, Inc. (SENS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 4:05 PM EST - 3 months ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 26, 2025, 7:30 AM EST - 3 months ago

Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care

Feb 13, 2025, 4:05 PM EST - 4 months ago

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 6, 2025, 4:05 PM EST - 4 months ago

Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Jan 8, 2025, 6:12 PM EST - 5 months ago

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting

Nov 7, 2024, 6:33 PM EST - 7 months ago

Senseonics Holdings, Inc. (SENS) Q3 2024 Earnings Call Transcript

Oct 16, 2024, 4:30 PM EDT - 8 months ago

Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

Oct 10, 2024, 4:10 PM EDT - 8 months ago

Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor

Oct 1, 2024, 11:00 AM EDT - 8 months ago

Eversense 365 Launches in the US: One Year. One CGM.

Sep 17, 2024, 7:00 AM EDT - 9 months ago

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

Sep 6, 2024, 4:05 PM EDT - 9 months ago

Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 6:07 PM EDT - 10 months ago

Senseonics Holdings, Inc. (SENS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 10 months ago

Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 4:05 PM EDT - 11 months ago

Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time

Jun 21, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook

Jun 13, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions

May 29, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

May 13, 2024, 7:52 PM EDT - 1 year ago

Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

May 13, 2024, 4:04 PM EDT - 1 year ago

Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management

May 9, 2024, 4:05 PM EDT - 1 year ago

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

May 2, 2024, 8:05 AM EDT - 1 year ago

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

Apr 30, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

Apr 30, 2024, 7:00 AM EDT - 1 year ago

Eversense® CGM System Receives iCGM Designation by the US FDA

Mar 12, 2024, 7:00 AM EDT - 1 year ago

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS

Mar 8, 2024, 8:05 AM EST - 1 year ago

Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

Mar 6, 2024, 8:05 AM EST - 1 year ago

Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference

Feb 29, 2024, 7:34 PM EST - 1 year ago

Senseonics Holdings, Inc. (SENS) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 15, 2024, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time

Feb 12, 2024, 7:00 AM EST - 1 year ago

Medicare Coverage Significantly Expanded for the Eversense E3 CGM System

Feb 12, 2024, 7:00 AM EST - 1 year ago

MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM

Feb 6, 2024, 8:00 AM EST - 1 year ago

PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care

Jan 2, 2024, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Announces Business Updates

Nov 9, 2023, 6:50 PM EST - 1 year ago

Senseonics Holdings, Inc. (SENS) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 8:05 AM EST - 1 year ago

Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference

Oct 30, 2023, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time

Oct 9, 2023, 7:00 AM EDT - 1 year ago

Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

Sep 26, 2023, 8:05 AM EDT - 1 year ago

Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study

Sep 14, 2023, 8:05 AM EDT - 1 year ago

Market Cap	344.71M
Revenue (ttm)	22.47M
Net Income (ttm)	-78.62M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-349.89%
Debt to Equity Ratio	0.99

Volume	5,619,800
Avg Vol	4,789,608
Day's Range	N/A - N/A
Shares Out	654.22M
Stochastic %K	43%
Beta	0.96
Analysts	Sell
Price Target	$1.55